cta-logo01
  • News

    Most Read

    • Can-Fite BioPharma enrols first patient to study Covid-19 drug
    • Ridgeback and Merck report preliminary data from Covid-19 trial
    • Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial

    Most Recent

    Clinical Trials

    Can-Fite BioPharma enrols first patient to study Covid-19 drug

    08 Mar 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Cuba’s homegrown Covid-19 vaccines advance into late-stage trials
    • OCT West Coast: the post-pandemic outlook for clinical trials
    • OCT West Coast: Covid-19’s impact on clinical trials

    Most Recent

    Infectious Diseases

    Cuba’s homegrown Covid-19 vaccines advance into late-stage trials

    05 Mar 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • Singapore reimagines what it means to be a business destination of choice
    • Can-Fite BioPharma enrols first patient to study Covid-19 drug
    • Ridgeback and Merck report preliminary data from Covid-19 trial

    Most Recent

    Sponsored

    Singapore reimagines what it means to be a business destination of choice

    08 Mar 2021
  • Themes
  • Deals

    Most Read

    • Altasciences completes acquisition of US-based CRO WCCT Global
    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink

    Most Recent

    Clinical Trials

    Altasciences completes acquisition of US-based CRO WCCT Global

    19 Feb 2021
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Kolabtree
    • VaLea Clinical Trials
    • Linari NanoTech

    Most Recent

    Clinical Trials

    Kolabtree

    24 Feb 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
Gilead’s Biktarvy shows durable viral suppression in HIV-1 trial

Gilead’s Biktarvy shows durable viral suppression in HIV-1 trial

Gilead Sciences has reported that new long-term data from open-label extensions (OLE) of two Phase...

8th March 2021
Ridgeback and Merck report preliminary data from Covid-19 trial

Ridgeback and Merck report preliminary data from Covid-19 trial

Merck and Ridgeback Biotherapeutics have reported preliminary results from a Phase IIa trial of investigational...

8th March 2021
Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial

Lilly’s tirzepatide leads to body weight reductions in type 2 diabetes trial

Eli Lilly and Company has reported that results from the SURPASS-2 clinical trial of tirzepatide...

5th March 2021
COSELA™ (trilaciclib) for the Treatment of Chemotherapy-Induced Myelosuppression, US

COSELA™ (trilaciclib) for the Treatment of Chemotherapy-Induced Myelosuppression, US

COSELA™ (trilaciclib) is the first approved myeloprotection therapy indicated to reduce the occurrence of chemotherapy-induced...

5th March 2021
Dicerna and Roche start Phase II trial of GalXC RNAi candidate in hepatitis B

Dicerna and Roche start Phase II trial of GalXC RNAi candidate in hepatitis B

Dicerna Pharmaceuticals and Roche have commenced the Phase II combination trial of investigational GalXC RNAi...

5th March 2021
Marker Therapeutics treats first subject in acute myeloid leukaemia trial

Marker Therapeutics treats first subject in acute myeloid leukaemia trial

Marker Therapeutics has treated the first patient in its Phase II trial of its lead...

4th March 2021
Lilly’s baricitinib meets primary endpoint in alopecia areata trial

Lilly’s baricitinib meets primary endpoint in alopecia areata trial

Eli Lilly and Company and Incyte have reported positive top-line results from Phase III BRAVE-AA2...

4th March 2021
Vir and GSK to halt enrolment in Covid-19 antibody trial

Vir and GSK to halt enrolment in Covid-19 antibody trial

Vir Biotechnology and GlaxoSmithKline (GSK) have reported that the independent Data and Safety Monitoring Board...

4th March 2021
Amgen reports positive data from BLINCYTO study in leukaemia patients

Amgen reports positive data from BLINCYTO study in leukaemia patients

Amgen has reported positive data from the Phase III study of BLINCYTO (blinatumomab) in paediatric...

3rd March 2021
Merck withdraws Keytruda from SCLC indication amid FDA crackdown

Merck withdraws Keytruda from SCLC indication amid FDA crackdown

On 1 March, Merck announced the voluntary withdrawal of its Keytruda (pembrolizumab) immunotherapy for the...

3rd March 2021

Latest News

Data Management

LSK Global selects Veeva’s clinical applications to simplify trial processes

08 Mar 2021
Clinical Trials

Globalisation of US cancer trials is reducing enrolment of Black patients, study finds

08 Mar 2021
Clinical Trials

Gilead’s Biktarvy shows durable viral suppression in HIV-1 trial

08 Mar 2021
Clinical Trials

Can-Fite BioPharma enrols first patient to study Covid-19 drug

08 Mar 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
CTArena_white-logo_

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more